Clinical Trial Update: Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A [Phase 4]

View source ↗

Summary

Phase 4 trial update for prophylaxis with recombinant Factor VIII manufactured protein-free (rAHF-PFM) in Hemophilia A; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rAHF-PFM (recombinant protein-free manufactured factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2012-11-20